Emerging Therapeutic Company Investment and Deal Trends

For more data on IPOs, follow-on offerings, out-licensing, and acquisitions, download a copy of our latest slides covering the first three quarters of 2020.

 

IPO-Slide
FOPO-Slide
Licensing-Slide---Upfront-Payments
M-Stage-Acquisitions

Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics and policy.